BGLC
#4966
BioNexus Gene Lab Corp - Common stock
1.5 5 USD
-0.03%
Market Price
Sector: Basic Materials
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-2.52%
Monthly Change
+5.44%
6 month change
-39.45%
Year Change
-30.96%
Previous Close
1.5 9
Open
1.5 5
Low
1.5 5
High
1.5 5
Volume
1
Financials
- Market Capitalization 4.55 M
- Employee 1
- Founded 2017
- CEO N/A
- Website www.bionexusgenelab.com
- Headquarter Wyoming, United States
- FIGI BBG00N70PLY0
- Industry Specialty Chemicals
Total revenue
Net income
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
—
Price to sales ratio
—
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4878 |  SNES SenesTech, Inc. - Common Stock | 1.20 USD | -4.76% | -0.83% | -14.29% | -48.72% | 6.51 M USD | ||
| 4939 |  YMAT J-Star Holding Co., Ltd. - Class A Ordinary Shares | 1.85 USD | +2.78% | -4.15% | 0.00% | -66.49% | 5.16 M USD | ||
| 5026 |  CNEY CN Energy Group Inc. - Class A Ordinary Shares | 0.63 USD | -10.00% | +6.78% | +14.55% | -72.96% | 3.14 M USD | ||
| 5358 |  SSL Sasol Ltd American Depositary Shares | 12.26 USD | -1.84% | +5.06% | +5.60% | +81.36% | 0 USD |
Frequently asked questions about BioNexus Gene Lab Corp Common stock
What is the BioNexus Gene Lab Corp Common stock stock price today?
The current price of BioNexus Gene Lab Corp Common stock (BGLC) is 1.55. Over the past 24 hours, the stock has changed by -2.52%. Follow the BGLC chart for real-time price dynamics.
What is the stock ticker of BioNexus Gene Lab Corp Common stock?
BioNexus Gene Lab Corp Common stock trades under the ticker BGLC. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is BioNexus Gene Lab Corp Common stock stock going up?
BGLC has changed by -6.63% over the last week, +5.44% over the last month, and -30.96% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of BioNexus Gene Lab Corp Common stock?
BioNexus Gene Lab Corp Common stock currently has a market capitalization of 4.55 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What was BioNexus Gene Lab Corp Common stock revenue for the last quarter?
BioNexus Gene Lab Corp Common stock reported quarterly revenue of 76.16 K. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was BioNexus Gene Lab Corp Common stock net income for the last quarter?
BioNexus Gene Lab Corp Common stock reported net income of -286.45 K for the last quarter. The previous quarter showed -543.58 K, which means net income changed by +47.30%.
How many employees does BioNexus Gene Lab Corp Common stock have?
As of the latest available data, BioNexus Gene Lab Corp Common stock has 1 employees. Workforce size can provide additional context about the company's scale and operations.
What is BioNexus Gene Lab Corp Common stock EBITDA?
BioNexus Gene Lab Corp Common stock EBITDA is -375.34 K, and its EBITDA margin is -492.85%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy BioNexus Gene Lab Corp Common stock stock?
You can buy BioNexus Gene Lab Corp Common stock (BGLC) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in BioNexus Gene Lab Corp Common stock stock?
Investing in BioNexus Gene Lab Corp Common stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the BGLC chart and related analysis on metatrader.com as part of your research.